116 related articles for article (PubMed ID: 10695819)
1. Extramedullary myeloid tumors in children: the limited value of local treatment.
Jenkin RD; Al-Shabanah M; Al-Nasser A; El-Solh H; Aur R; Al Sudairy R; Mustafa MM; Al Fawaz I; Gray A; da Cunha M; Ayas M; Al Mahr M; Kofide A; Mahgoub AN; Rifai S; Belgaumi A; Al Jefri A; Al Musa A; Sabbah R
J Pediatr Hematol Oncol; 2000; 22(1):34-40. PubMed ID: 10695819
[TBL] [Abstract][Full Text] [Related]
2. Isolated extramedullary relapse in acute myeloid leukemia: A retrospective analysis.
Ginsberg JP; Orudjev E; Bunin N; Felix CA; Lange BJ
Med Pediatr Oncol; 2002 Jun; 38(6):387-90. PubMed ID: 11984798
[TBL] [Abstract][Full Text] [Related]
3. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse.
Choi SJ; Lee JH; Lee JH; Kim S; Seol M; Lee YS; Lee JS; Kim WK; Chi HS; Lee KH
Leukemia; 2004 Nov; 18(11):1789-97. PubMed ID: 15385924
[TBL] [Abstract][Full Text] [Related]
4. Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia.
Wahlin A; Brinch L; Hörnsten P; Evensen SA; Oberg G; Simonsson B; Hedenus M
Eur J Haematol; 1997 Apr; 58(4):233-40. PubMed ID: 9186533
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow transplantation in acute myeloid leukemia: the University of Minnesota experience.
Dusenbery KE; Steinbuch M; McGlave PB; Ramsay NK; Blazar BR; Neglia JP; Litz C; Kersey JH; Woods WG
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):335-43. PubMed ID: 8892457
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821.
Chang M; Raimondi SC; Ravindranath Y; Carroll AJ; Camitta B; Gresik MV; Steuber CP; Weinstein H
Leukemia; 2000 Jul; 14(7):1201-7. PubMed ID: 10914543
[TBL] [Abstract][Full Text] [Related]
9. Factors Determining the Outcome of Hematopoietic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Al-Sweedan S; Al-Seraihy A; Al-Ahmari A; Al-Jefri A; Mohammed V; Jafri R; Siddiqui K; Ayas M
J Pediatr Hematol Oncol; 2017 Jan; 39(1):33-37. PubMed ID: 27906795
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group.
Nesbit ME; Buckley JD; Feig SA; Anderson JR; Lampkin B; Bernstein ID; Kim TH; Piomelli S; Kersey JH; Coccia PF
J Clin Oncol; 1994 Jan; 12(1):127-35. PubMed ID: 8270968
[TBL] [Abstract][Full Text] [Related]
11. Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis.
Godder K; Eapen M; Laver JH; Zhang MJ; Camitta BM; Wayne AS; Gale RP; Doyle JJ; Yu LC; Chen AR; Garvin JH; Sandler ES; Yeager AM; Edwards JR; Horowitz MM
J Clin Oncol; 2004 Sep; 22(18):3798-804. PubMed ID: 15365077
[TBL] [Abstract][Full Text] [Related]
12. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
Aladjidi N; Auvrignon A; Leblanc T; Perel Y; Bénard A; Bordigoni P; Gandemer V; Thuret I; Dalle JH; Piguet C; Pautard B; Baruchel A; Leverger G;
J Clin Oncol; 2003 Dec; 21(23):4377-85. PubMed ID: 14645428
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
J Clin Oncol; 2005 Dec; 23(36):9172-8. PubMed ID: 16361619
[TBL] [Abstract][Full Text] [Related]
14. Clinical and imaging characteristics of orbital leukemic tumors.
Bidar M; Wilson MW; Laquis SJ; Wilson TD; Fleming JC; Wesley RE; Ribeiro RC; Haik BG
Ophthalmic Plast Reconstr Surg; 2007; 23(2):87-93. PubMed ID: 17413619
[TBL] [Abstract][Full Text] [Related]
15. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.
Fagioli F; Bacigalupo A; Frassoni F; Van Lint MT; Occhini D; Gualandi F; Lamparelli T; Clavio M; Vitale V; Sogno G
Bone Marrow Transplant; 1994 Mar; 13(3):247-52. PubMed ID: 8199567
[TBL] [Abstract][Full Text] [Related]
17. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K
Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514
[TBL] [Abstract][Full Text] [Related]
18. Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants.
Shank B; Chu FC; Dinsmore R; Kapoor N; Kirkpatrick D; Teitelbaum H; Reid A; Bonfiglio P; Simpson L; O'Reilly RJ
Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1607-11. PubMed ID: 6358154
[TBL] [Abstract][Full Text] [Related]
19. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
